Sonoscape announces 2025 equity incentive plan for key personnel

Sonoscape Medical Corp. issued announcements on September 16, 2025, detailing its 2025 Restricted Stock and Stock Option Incentive Plan. The plan was approved by the Fourth Board of Directors' Tenth Meeting and the Fourth Supervisory Board's Ninth Meeting on September 4, 2025. Both the supervisory board and the board's remuneration and assessment committee verified the list of incentive recipients.

The incentive plan's draft, summary, and list of recipients were publicly disclosed on the Juchao Information website on September 6, 2025. Concurrently, the list of eligible individuals, including their names and positions, was internally posted from September 6 to September 15, 2025. No objections or negative feedback were received during this public display period.

Both the supervisory board and the board's remuneration and assessment committee confirmed that all listed incentive recipients meet the eligibility criteria outlined in relevant company and securities laws and self-regulatory guidance. The recipients include directors, senior management, middle management, and technical backbone staff, excluding independent directors, supervisors, foreign employees, and shareholders holding 5% or more of the company's shares.